Table 2.
Life expectancy of persons diagnosed with HIV infection by year of diagnosis, overall and by selected characteristics, 2008–2011, United States.
| Year of diagnosis | 2008 | 2009 | 2010 | 2011 |
|---|---|---|---|---|
| Number of Diagnoses3 | 49,061 | 46,403 | 44,931 | 44,354 |
|
| ||||
| ELE (95% CI) 4 | ELE (95% CI)2 | ELE (95% CI) 2 | ELE (95% CI) 2 | |
| Overall Life Expectancy | 25.43 (25.37–25.49) |
26.22 (26.16–26.28) |
27.33 (27.27–27.39) |
28.86 (28.8–28.92) |
|
| ||||
| Sex | ||||
| Males | 26.03 (25.96–26.1) |
26.88 (26.81–26.95) |
28.13 (28.06–28.19) |
29.67 (29.60–29.74) |
| Females | 23.75 (23.62–23.89) |
24.32 (24.19–24.44) |
25.01 (24.88–25.14) |
26.40 (26.27–26.52) |
|
| ||||
| Race/Ethnicity | ||||
| Black/African American | 23.68 (23.59–23.76) |
24.76 (24.67–24.85) |
26.39 (26.3–26.48) |
28.45 (28.37–28.54) |
| Hispanic/Latino | 28.27 (28.12–28.41) |
28.89 (28.75–29.03) |
29.84 (29.70–29.97) |
30.79 (30.65–30.93) |
| White | 25.69 (25.59–25.8) |
26.26 (26.15–26.36) |
26.85 (26.74–26.95) |
27.77 (27.66–27.88) |
| Other races/ethnicities | 24.71 (24.49–24.93) |
24.32 (24.18–24.46) |
24.83 (24.6–25.05) |
26.13 (25.97–26.29) |
|
| ||||
| Stage at diagnosis | ||||
| Stage 3 | 20.81 (20.67–20.95) |
21.69 (21.55–21.83) |
22.59 (22.45–22.73) |
24.00 (23.86–24.14) |
| Other than stage 35 | 27.39 (27.32–27.45) |
28.08 (28.02–28.14) |
29.32 (29.26–29.38) |
30.83 (30.78–30.89) |
| Transmission Category—Males | ||||
| Male-to-male sexual contact
(MSM) |
29.31 (29.22-29.41) |
30.23 (30.14-30.32) |
31.18 (31.09-31.27) |
32.30 (32.22-32.39) |
| Injection drug use (IDU) | 17.86 (17.67-18.04) |
17.98 (17.79-18.17) |
18.62 (18.40-18.84) |
20.24 (20.00-20.48) |
| Male-to-male sexual contact and
injection drug use (MSM-IDU) |
23.31 (23.08-23.55) |
23.25 (22.98-23.52) |
24.87 (24.60-25.13) |
26.31 (26.03-26.59) |
| Heterosexual contact | 20.80 (20.63-20.97) |
21.61 (21.43-21.80) |
22.49 (22.32-22.66) |
23.45 (23.28-23.61) |
| Transmission Category—Females | ||||
| Injection drug use (IDU) | 18.70 (18.47-18.94) |
19.76 (19.53-20.00) |
20.45 (20.17-20.72) |
21.36 (21.08-21.64) |
| Heterosexual contact | 25.94 (25.77-26.11) |
26.08 (25.93-26.24) |
26.49 (26.34-26.65) |
27.90 (27.75-28.05) |
3
Totals include persons with HIV transmission attributed to infrequent causes such as hemophilia etc.
4
Estimated life expectancy and 95% confidence intervals.
5
Includes stage unknown